Connect with us

Technology

Endeavor Analytics is Revolutionizing Health Care Insights With New Product, CorrelateIQ

Published

2 years ago

on

Powered by Amazon Web Services, CorrelateIQ Brings Valuable Insights to Empower Decision Making

CLEVELAND, March 4, 2025 /PRNewswire/ — The Center for Health Affairs and Endeavor Management announce the formation of a groundbreaking joint venture, Endeavor Analytics, LLC. Headquartered in Cleveland, Ohio, Endeavor Analytics combines the expertise and assets of both founding organizations to tackle the health care industry’s most complex challenges while serving as a catalyst for economic growth in the region. The new venture plans to create jobs and foster corporate development in Cleveland, positioning the city as a hub for health care innovation.

Leading this exciting new initiative is Orlando L. Alvarez, Jr., who has been named executive director of Endeavor Analytics. A highly respected health care executive with over three decades of experience, Alvarez has held strategic leadership roles at prestigious institutions, including Cleveland Clinic Florida, Sisters of Charity Health System, and the University of Miami Health System. A resident of Shaker Heights, Ohio, Alvarez brings a wealth of knowledge and a proven track record to this leadership role.

Accelerating Insights: From Data to Action in Weeks, Not Months  

Endeavor Analytics will offer a suite of services designed to transform raw data into actionable insights at unprecedented speeds. Its flagship product, CorrelateIQ, is an innovative platform powered by Amazon Web Services (AWS). CorrelateIQ streamlines the ingestion and harmonization of large, disparate datasets, delivering elegant visualizations and insights that empower decision-making. Initial CorrelateIQ solutions include:

Price Transparency Insights – A game-changing tool that delivers market intelligence on competitor rates with multiple health care payors.

Benchmarking and Dashboarding – Taking large and disparate external and internal, market, and patient data sets and creating data measures and dashboards for active monitoring and strategy development.

Convenings – Thought leadership and think tank for tackling the toughest issues, bringing together experts and practitioners to share challenges and solutions guided by data and analytics curated by CorrelateIQ.

These offerings are part of an ambitious product development pipeline, with additional solutions to be launched in the coming months.

“Finding ways to accelerate data analysis and providing fact-based insights will be a game changer. CorrelateIQ will bring solutions that can be harnessed not only in health care but in other industries as well,” explains Alvarez.

Beyond Data: Advisory Services to Drive Implementation  

Recognizing that insights are only as valuable as their execution, Endeavor Analytics will also provide comprehensive advisory services. Backed by Endeavor Management’s network of more than 350 consulting professionals, including distinguished Executives in Residence—a roster of former C-suite executives from leading health care organizations—Endeavor Analytics ensures not only the delivery of insights but also the expertise needed to implement them effectively.

Endeavor Analytics will benefit from the significant assets of its parent organizations. These include The Center for Health Affairs, a 110-year-old association working with 37 hospital and healthcare organizations, and CHAMPS Group Purchasing, a nationwide network with over 26,000 member locations. These resources position Endeavor Analytics to deliver innovative, impactful solutions on a national scale.

“We are excited to partner with Endeavor Management on this new venture,” said Brian Lane, president and CEO of The Center for Health Affairs and CHAMPS. “Hospitals across the country are facing financial challenges. Through Endeavor Analytics and its powerful suite of solutions, CorrelateIQ, hospitals and health systems will gain invaluable business intelligence, filling a critical gap in their ability to stabilize financially. CorrelateIQ gets to the heart of what we at The Center are seeking to do: link with partners to provide solutions that can positively impact medical, social, and economic health, and transform total well-being.”

About Endeavor Analytics  

Endeavor Analytics is a joint venture between The Center for Health Affairs and Endeavor Management, dedicated to solving the healthcare industry’s most pressing challenges through bridging data and action. By combining innovative technology with deep expertise, Endeavor Analytics empowers leading health care organizations to drive meaningful change backed by data, dashboards, insights, and innovative strategies. Headquartered in Cleveland, Ohio, Endeavor Analytics is poised to become a driver of economic and health care innovation.

About Endeavor Management

Endeavor Management is a global strategic advisory firm specializing in energy, healthcare, and industrial sectors. With a commitment to excellence and innovation, Endeavor Management provides strategic solutions to help organizations navigate complex challenges and achieve sustainable growth.

About The Center for Health Affairs

With a rich history as the nation’s first regional hospital association and a mission to impact medical, social and economic health and well-being, The Center for Health Affairs convenes 37 hospital and healthcare organizations along with community partners across 10 counties in Northeast Ohio. With a dedicated and consistent history dating back over 100 years, The Center aims to enhance the effectiveness of the healthcare community and the health of the communities it serves by providing expertise, resources and solutions to address the challenges currently being faced by the region’s healthcare providers. The Center’s efforts focus on areas in which hospitals and their communities can benefit from a regional approach, including emergency preparedness; behavioral health; public policy and advocacy; finance and reimbursement; and social determinants of health. Through its business affiliates, CHAMPS Group Purchasing and The Essentials Group, The Center provides a broad level of professional services to its members. For more, visit neohospitals.org.

Press Contact:

Michele Fancher
2162553657
https://endeavormgmt.com/endeavor-analytics

View original content to download multimedia:https://www.prnewswire.com/news-releases/endeavor-analytics-is-revolutionizing-health-care-insights-with-new-product-correlateiq-302391407.html

SOURCE Endeavor Analytics

Related Topics:
Continue Reading

Technology

MiniTool ShadowMaker 5.0 Introduces Cloud Sync for Google Drive and OneDrive

Published

55 minutes ago

on

October 23, 2026

By

VANCOUVER, BC, Oct. 22, 2026 /PRNewswire/ — MiniTool® Software Limited has announced the release of MiniTool ShadowMaker 5.0, the latest version of its Windows backup and file sync software. The update introduces a new Cloud Sync feature for Google Drive and OneDrive, along with enhancements to the registration and purchase experience, interface refinements, and compatibility fixes.

New Features and Improvements in MiniTool ShadowMaker 5.0

1. Cloud Sync to Google Drive and OneDrive

MiniTool ShadowMaker 5.0 introduces Cloud Sync, allowing users to synchronize files and folders from a Windows computer to Google Drive or OneDrive. Users can choose the files and folders they want to sync and select their preferred cloud storage service as the destination.

The new feature supports one-way synchronization from a local Windows PC to cloud storage, providing an additional way to save copies of important files outside of your computer. Together with MiniTool ShadowMaker’s existing local file sync function, Cloud Sync expands the available destinations for file sync.

2. Streamlined License & Plan Management

The latest update introduces an enhanced register interface that remains easily accessible even after activation. Registered users can now effortlessly review their current plan, explore upgrade options, or update their license key anytime for a smoother user experience.

These refinements are intended to improve usability when users manage their software registration and licensing.

3. Interface Refinements and Compatibility Fixes

MiniTool ShadowMaker 5.0 includes interface improvements and fixes for certain display issues. One notable fix addresses a blurry display issue that could occur on some systems equipped with AMD GPUs.

These changes focus on resolving specific issues and improving the user experience on affected systems.

4. Additional Improvements

Beyond Cloud Sync and the changes outlined above, MiniTool ShadowMaker 5.0 includes additional interface and functionality refinements. Together, these updates further improve the software’s usability while expanding its file synchronization options.

With support for Google Drive and OneDrive, MiniTool ShadowMaker 5.0 provides Windows users with another approach to manage file copies across local and cloud storage. Users who want to synchronize files to cloud storage can download the Free Edition and explore the new capabilities.

About MiniTool ShadowMaker

MiniTool ShadowMaker is a Windows backup and file sync solution designed to help users protect their operating systems and important data. It supports backing up Windows systems, disks, partitions, files, and folders to local drives, external hard drives, shared folders, and other supported locations. Users can select specific items to back up according to their needs.

For users who need to migrate data to another drive, MiniTool ShadowMaker offers a disk cloning feature. The software also supports restoring backed-up data and creating bootable media for system recovery.

By combining backup, file synchronization, disk cloning, and restore capabilities, MiniTool ShadowMaker offers Windows users a set of tools for data protection and system recovery.

About MiniTool® Software Limited

MiniTool Software Limited is a professional software company that develops computer applications. It provides software for partition management, data recovery, data backup and sync, video editing, multimedia conversion, and screen recording for home and business users. The company is committed to developing innovative, reliable, and easy-to-use software that simplifies everyday digital tasks.

View original content to download multimedia:https://www.prnewswire.com/news-releases/minitool-shadowmaker-5-0-introduces-cloud-sync-for-google-drive-and-onedrive-302916663.html

SOURCE MiniTool® Software Limited

Continue Reading

Technology

Rocket Companies to Announce Third Quarter 2026 Results on October 29, 2026

Published

2 hours ago

on

October 22, 2026

By

DETROIT, Oct. 22, 2026 /PRNewswire/ — Rocket Companies, Inc. (NYSE: RKT) (“Rocket Companies” or “the Company”), the Detroit-based homeownership platform, today announced that the Company will issue its third quarter 2026 earnings on October 29, 2026. Leadership will host a conference call to discuss results at 4:30 p.m. ET on that date. A press release detailing the Company’s results will be issued prior to the call.

A live webcast of the event will be available on the “Events & Presentations” section of the Company’s Investor Relations website at ir.rocketcompanies.com. A replay of the webcast will be available on the Investor Relations website following the event.

About Rocket Companies

Founded in 1985, Rocket Companies (NYSE: RKT) is a Detroit-based homeownership platform including mortgage, real estate and personal finance businesses: Rocket Mortgage, Redfin, Rocket Close, Rocket Money and Rocket Loans.

With insights from more than 160 million calls with clients each year, more than 30 petabytes of data and a mission to Help Everyone Home, Rocket Companies is well positioned to be the destination for AI-fueled homeownership.

For more information, please visit the Company’s Corporate website or Investor Relations website.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rocket-companies-to-announce-third-quarter-2026-results-on-october-29-2026-302917496.html

SOURCE Rocket Companies, Inc.

Continue Reading

Technology

Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister

Published

2 hours ago

on

October 22, 2026

By

SACRAMENTO, Calif., Oct. 22, 2026 /PRNewswire/ — Lunai Bioworks Inc. (Nasdaq: LNAI) (the “Company”) announced that on October 21, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000. The Company reported a stockholders’ deficit of $(9,024,946) in its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, and does not meet the alternative market value of listed securities or net income standards. Because the Company is subject to a mandatory Hearings Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(B), Nasdaq staff determined to delist the Company’s securities. Trading in the Company’s common stock on Nasdaq is expected to be suspended at the opening of business on October 30, 2026.

The Company will not request a hearing. Rather than contest the staff determination, the Company’s Board of Directors approved on October 22, 2026 the voluntary withdrawal of the Company’s common stock from listing on Nasdaq under Rule 12d2-2(c) under the Securities Exchange Act of 1934, as amended. The Board took this action because of the staff determination and the Company’s financial condition, and concluded that the cost of continued listing and SEC reporting is not justified.

The Company notified Nasdaq of its intention on October 22, 2026. The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) on or about November 2, 2026, and expects the delisting to become effective on or about November 12, 2026. The Company then intends to file a Form 15 to suspend its SEC reporting obligations, to the extent it is eligible to do so. The Company’s SEC reporting obligations will continue unless and until they are terminated or suspended in accordance with the SEC’s rules.

The Company does not intend to arrange for quotation of its common stock on any over-the-counter market and cannot assure that any trading market for its common stock will exist after trading on Nasdaq is suspended.

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the expected suspension of trading, the expected timing of the Form 25 and Form 15 filings, and the expected timing of delisting and deregistration. Actual results may differ materially due to risks and uncertainties, including Nasdaq and SEC procedures and the Company’s financial condition. The Company undertakes no obligation to update these statements, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lunai-bioworks-announces-receipt-of-nasdaq-determination-and-intention-to-voluntarily-delist-and-deregister-302917510.html

SOURCE Lunai Bioworks Inc.

Continue Reading

Trending